{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:25:56Z","timestamp":1791617156508,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteochondral lesions of the talus (OLT) are common after ankle trauma. Studies have shown that bioactive substances, such as hyaluronic acid (HA), alone, or in combination, with surgical treatment could improve cartilage regeneration and repair, but the effect of HA on patient reported outcomes is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Literature searches were performed across four databases (PubMed, SPORTDiscus, Scopus, and The Cochrane Library) for randomized controlled trials in which at least one treatment arm involved use of HA as an adjunct to microfracture to treat patients with OLT. Primary outcomes included the American Orthopaedic Foot and Ankle Society scores (AOFAS), and the Visual Analog Scale (VAS) for pain. The level of evidence and methodological quality were evaluated using the Modified Coleman Methodology Score (MCMS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three randomized studies were eligible for review with a total of 132 patients (35, 40, 57 patients, respectively) and follow-up ranged from 10.5 to 25\u2009months. Utilization of HA at the time of microfracture resulted in greater improvement in AOFAS scores compared to microfracture alone. The pooled effect size was moderate (Standardized Mean Difference [SMD] 0.45, 95% Confidence Interval [CI] 0.06, 0.84; <jats:italic>P<\/jats:italic>\u2009=\u2009.02) and between-study heterogeneity was low (I-squared\u2009=\u20090%). Utilization of HA during microfracture also led to greater improvement in VAS-pain scores compared to microfracture alone. The pooled effect size was very large (SMD -3.86, 95% CI -4.75, \u2212\u20092.97; <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001) and heterogeneity was moderate (I-squared\u2009=\u200969%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hyaluronic acid injection as an adjunct to arthroscopic MF in OLT provides clinically important improvements in function and pain at short-term follow-up compared to MF alone. Future longer-term follow-up studies are\u00a0warranted to investigate the durability of MF with HA for treatment of OLT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-022-05236-6","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:03:06Z","timestamp":1648890186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hyaluronic acid as an adjunct to microfracture in the treatment of osteochondral lesions of the talus: a systematic review of randomized controlled trials"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-3412","authenticated-orcid":false,"given":"Julian E.","family":"Dilley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-5409","authenticated-orcid":false,"given":"Joshua S.","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Klitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"issue":"3","key":"5236_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.injury.2015.10.029","volume":"47","author":"M Regier","year":"2016","unstructured":"Regier M, Petersen JP, Hamurcu A, Vettorazzi E, Behzadi C, Hoffmann M, et al. High incidence of osteochondral lesions after open reduction and internal fixation of displaced ankle fractures: medium-term follow-up of 100 cases. Injury. 2016;47(3):757\u201361.","journal-title":"Injury"},{"issue":"4","key":"5236_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/17453674.2018.1460777","volume":"89","author":"SG Seo","year":"2018","unstructured":"Seo SG, Kim JS, Seo DK, Kim YK, Lee SH, Lee HS. Osteochondral lesions of the talus. Acta Orthop. 2018;89(4):462\u20137.","journal-title":"Acta Orthop"},{"issue":"5","key":"5236_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00167-010-1064-x","volume":"18","author":"CN van Dijk","year":"2010","unstructured":"van Dijk CN, Reilingh ML, Zengerink M, van Bergen CJ. Osteochondral defects in the ankle: why painful? Knee Surg Sports Traumatol Arthrosc. 2010;18(5):570\u201380.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"10","key":"5236_CR4","doi-asserted-by":"publisher","first-page":"232596711987623","DOI":"10.1177\/2325967119876238","volume":"7","author":"JAH Steman","year":"2019","unstructured":"Steman JAH, Dahmen J, Lambers KTA, Kerkhoffs G. Return to sports after surgical treatment of osteochondral defects of the talus: a systematic review of 2347 cases. Orthop J Sports Med. 2019;7(10):2325967119876238.","journal-title":"Orthop J Sports Med."},{"issue":"7","key":"5236_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/107110070202300712","volume":"23","author":"C Shearer","year":"2002","unstructured":"Shearer C, Loomer R, Clement D. Nonoperatively managed stage 5 osteochondral talar lesions. Foot Ankle Int. 2002;23(7):651\u20134.","journal-title":"Foot Ankle Int"},{"issue":"9","key":"5236_CR6","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00264-013-2076-1","volume":"37","author":"T Badekas","year":"2013","unstructured":"Badekas T, Takvorian M, Souras N. Treatment principles for osteochondral lesions in foot and ankle. Int Orthop. 2013;37(9):1697\u2013706.","journal-title":"Int Orthop"},{"issue":"5","key":"5236_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00167-009-1036-1","volume":"18","author":"C Becher","year":"2010","unstructured":"Becher C, Driessen A, Hess T, Longo UG, Maffulli N, Thermann H. Microfracture for chondral defects of the talus: maintenance of early results at midterm follow-up. Knee Surg Sports Traumatol Arthrosc. 2010;18(5):656\u201363.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"2","key":"5236_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00167-009-0914-x","volume":"18","author":"KB Lee","year":"2010","unstructured":"Lee KB, Bai LB, Chung JY, Seon JK. Arthroscopic microfracture for osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2010;18(2):247\u201353.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"1","key":"5236_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0363546519887957","volume":"48","author":"SW Choi","year":"2020","unstructured":"Choi SW, Lee GW, Lee KB. Arthroscopic microfracture for osteochondral lesions of the talus: functional outcomes at a mean of 6.7 years in 165 consecutive ankles. Am J Sports Med. 2020;48(1):153\u20138.","journal-title":"Am J Sports Med"},{"issue":"1","key":"5236_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.arthro.2007.07.022","volume":"24","author":"B Chuckpaiwong","year":"2008","unstructured":"Chuckpaiwong B, Berkson EM, Theodore GH. Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases. Arthroscopy. 2008;24(1):106\u201312.","journal-title":"Arthroscopy"},{"issue":"9","key":"5236_CR11","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1177\/0363546508316773","volume":"36","author":"RD Ferkel","year":"2008","unstructured":"Ferkel RD, Zanotti RM, Komenda GA, Sgaglione NA, Cheng MS, Applegate GR, et al. Arthroscopic treatment of chronic osteochondral lesions of the talus: long-term results. Am J Sports Med. 2008;36(9):1750\u201362.","journal-title":"Am J Sports Med"},{"issue":"4","key":"5236_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00167-016-3990-8","volume":"24","author":"G Polat","year":"2016","unstructured":"Polat G, Ersen A, Erdil ME, Kizilkurt T, Kilicoglu O, Asik M. Long-term results of microfracture in the treatment of talus osteochondral lesions. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1299\u2013303.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"8","key":"5236_CR13","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/jor.24597","volume":"38","author":"BT Peal","year":"2020","unstructured":"Peal BT, Gagliardi R, Su J, Fortier LA, Delco ML, Nixon AJ, et al. Synovial fluid lubricin and hyaluronan are altered in equine osteochondral fragmentation, cartilage impact injury, and full-thickness cartilage defect models. J Orthop Res. 2020;38(8):1826\u201335.","journal-title":"J Orthop Res"},{"issue":"5","key":"5236_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.apmr.2012.10.030","volume":"94","author":"KV Chang","year":"2013","unstructured":"Chang KV, Hsiao MY, Chen WS, Wang TG, Chien KL. Effectiveness of intra-articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2013;94(5):951\u201360.","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"5236_CR15","first-page":"288","volume":"26","author":"V Karatosun","year":"2008","unstructured":"Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I. Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol. 2008;26(2):288\u201394.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"5236_CR16","first-page":"295","volume":"88","author":"RS Salk","year":"2006","unstructured":"Salk RS, Chang TJ, D'Costa WF, Soomekh DJ, Grogan KA. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am. 2006;88(2):295\u2013302.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"5236_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2106\/JBJS.J.01763","volume":"94","author":"H DeGroot 3rd","year":"2012","unstructured":"DeGroot H 3rd, Uzunishvili S, Weir R, Al-omari A, Gomes B. Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am. 2012;94(1):2\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"5236_CR18","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1055\/s-0039-3402742","volume":"32","author":"J Farr","year":"2019","unstructured":"Farr J, Gomoll AH, Yanke AB, Strauss EJ, Mowry KC, Group ASAS. Erratum to: a randomized controlled single-blind study demonstrating superiority of amniotic suspension allograft injection over hyaluronic acid and saline control for modification of knee osteoarthritis symptoms. J Knee Surg. 2019;32(11):e2.","journal-title":"J Knee Surg"},{"issue":"10","key":"5236_CR19","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s10067-020-05121-4","volume":"39","author":"FN Kesiktas","year":"2020","unstructured":"Kesiktas FN, Dernek B, Sen EI, Albayrak HN, Aydin T, Yildiz M. Comparison of the short-term results of single-dose intra-articular peptide with hyaluronic acid and platelet-rich plasma injections in knee osteoarthritis: a randomized study. Clin Rheumatol. 2020;39(10):3057\u201364.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5236_CR20","first-page":"111","volume":"45","author":"MH Jokar","year":"2020","unstructured":"Jokar MH, Mirfeizi Z, Zarei H, Hashemzadeh K. Intra-articular hyaluronic acid injection vs. atorvastatin; which treatment is more effective in controlling symptoms of knee osteoarthritis? A clinical trial. Acta Reumatol Port. 2020;45(2):111\u20135.","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"5236_CR21","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/ar4446","volume":"16","author":"M Ishijima","year":"2014","unstructured":"Ishijima M, Nakamura T, Shimizu K, Hayashi K, Kikuchi H, Soen S, et al. Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial. Arthritis Res Ther. 2014;16(1):R18.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5236_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12891-019-2546-8","volume":"20","author":"J Hermans","year":"2019","unstructured":"Hermans J, Bierma-Zeinstra SMA, Bos PK, Niesten DD, Verhaar JAN, Reijman M. The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial. BMC Musculoskelet Disord. 2019;20(1):196.","journal-title":"BMC Musculoskelet Disord"},{"key":"5236_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13075-015-0557-x","volume":"17","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zhang K, Zhang X, Zhu Z, Yan S, Sun T, et al. Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Res Ther. 2015;17:51.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5236_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.joca.2013.10.009","volume":"22","author":"R Leighton","year":"2014","unstructured":"Leighton R, Akermark C, Therrien R, Richardson JB, Andersson M, Todman MG, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-Centre, randomized, non-inferiority trial. Osteoarthr Cartil. 2014;22(1):17\u201325.","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"5236_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.joca.2012.01.013","volume":"20","author":"V Strand","year":"2012","unstructured":"Strand V, Baraf HSB, Lavin PT, Lim S, Hosokawa H. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthr Cartil. 2012;20(5):350\u20136.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"5236_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12891-017-1585-2","volume":"18","author":"Y Henrotin","year":"2017","unstructured":"Henrotin Y, Berenbaum F, Chevalier X, Marty M, Richette P, Rannou F. Reduction of the serum levels of a specific biomarker of cartilage degradation (Coll2-1) by hyaluronic acid (KARTILAGE(R) CROSS) compared to placebo in painful knee osteoarthritis patients: the EPIKART study, a pilot prospective comparative randomized double blind trial. BMC Musculoskelet Disord. 2017;18(1):222.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"5236_CR27","doi-asserted-by":"publisher","first-page":"e0150020","DOI":"10.1371\/journal.pone.0150020","volume":"11","author":"F Pohlig","year":"2016","unstructured":"Pohlig F, Guell F, Lenze U, Lenze FW, Muhlhofer HM, Schauwecker J, et al. Hyaluronic acid suppresses the expression of metalloproteinases in osteoarthritic cartilage stimulated simultaneously by interleukin 1beta and Mechanical load. Plos One. 2016;11(3):e0150020.","journal-title":"Plos One"},{"issue":"5","key":"5236_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3899\/jrheum.130378","volume":"41","author":"Z Mladenovic","year":"2014","unstructured":"Mladenovic Z, Saurel AS, Berenbaum F, Jacques C. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts. J Rheumatol. 2014;41(5):945\u201354.","journal-title":"J Rheumatol"},{"issue":"8","key":"5236_CR29","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s10067-006-0504-y","volume":"26","author":"A Kalaci","year":"2007","unstructured":"Kalaci A, Yilmaz HR, Aslan B, Sogut S, Yanat AN, Uz E. Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritis. Clin Rheumatol. 2007;26(8):1306\u201311.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5236_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00011-010-0156-x","volume":"59","author":"H Peng","year":"2010","unstructured":"Peng H, Zhou JL, Liu SQ, Hu QJ, Ming JH, Qiu B. Hyaluronic acid inhibits nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes in vitro. Inflamm Res. 2010;59(7):519\u201330.","journal-title":"Inflamm Res"},{"issue":"2","key":"5236_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","volume":"156","author":"S Mizrahy","year":"2011","unstructured":"Mizrahy S, Raz SR, Hasgaard M, Liu H, Soffer-Tsur N, Cohen K, et al. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J Control Release. 2011;156(2):231\u20138.","journal-title":"J Control Release"},{"issue":"4","key":"5236_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4103\/0019-5413.185607","volume":"50","author":"C Alemdar","year":"2016","unstructured":"Alemdar C, Yucel I, Erbil B, Erdem H, Atic R, Ozkul E. Effect of insulin-like growth factor-1 and hyaluronic acid in experimentally produced osteochondral defects in rats. Indian J Orthop. 2016;50(4):414\u201320.","journal-title":"Indian J Orthop"},{"issue":"4","key":"5236_CR33","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s10856-013-5139-3","volume":"25","author":"T Fukui","year":"2014","unstructured":"Fukui T, Kitamura N, Kurokawa T, Yokota M, Kondo E, Gong JP, et al. Intra-articular administration of hyaluronic acid increases the volume of the hyaline cartilage regenerated in a large osteochondral defect by implantation of a double-network gel. J Mater Sci Mater Med. 2014;25(4):1173\u201382.","journal-title":"J Mater Sci Mater Med"},{"issue":"12","key":"5236_CR34","doi-asserted-by":"publisher","first-page":"e0209747","DOI":"10.1371\/journal.pone.0209747","volume":"13","author":"HC Wang","year":"2018","unstructured":"Wang HC, Lin YT, Lin TH, Chang NJ, Lin CC, Hsu HC, et al. Intra-articular injection of N-acetylglucosamine and hyaluronic acid combined with PLGA scaffolds for osteochondral repair in rabbits. Plos One. 2018;13(12):e0209747.","journal-title":"Plos One"},{"issue":"12","key":"5236_CR35","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1177\/0363546509339579","volume":"37","author":"LD Kaplan","year":"2009","unstructured":"Kaplan LD, Lu Y, Snitzer J, Nemke B, Hao Z, Biro S, et al. The effect of early hyaluronic acid delivery on the development of an acute articular cartilage lesion in a sheep model. Am J Sports Med. 2009;37(12):2323\u20137.","journal-title":"Am J Sports Med"},{"issue":"4","key":"5236_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/0363546508328415","volume":"37","author":"EMS Strauss","year":"2009","unstructured":"Strauss EMS. Aaron MD; Frenkel, Sally PhD; Rosen, Jeffrey MD. The efficacy of intra-articular Hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions. Am J Sports Med. 2009;37(4):720\u20136.","journal-title":"Am J Sports Med"},{"issue":"11","key":"5236_CR37","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1177\/1071100720945944","volume":"41","author":"YG Hwang","year":"2020","unstructured":"Hwang YG, Lee JW, Park KH, Hsienhao C, Han SH. Intra-articular injections of hyaluronic acid on osteochondral lesions of the talus after failed arthroscopic bone marrow stimulation. Foot Ankle Int. 2020;41(11):1376\u201382.","journal-title":"Foot Ankle Int"},{"issue":"5","key":"5236_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.aott.2019.04.002","volume":"53","author":"NS Yontar","year":"2019","unstructured":"Yontar NS, Aslan L, Can A, Ogut T. One step treatment of talus osteochondral lesions with microfracture and cell free hyaluronic acid based scaffold combination. Acta Orthop Traumatol Turc. 2019;53(5):372\u20135.","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"12","key":"5236_CR39","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3113\/FAI.2008.1171","volume":"29","author":"O Mei-Dan","year":"2008","unstructured":"Mei-Dan O, Maoz G, Swartzon M, Onel E, Kish B, Nyska M, et al. Treatment of osteochondritis dissecans of the ankle with hyaluronic acid injections: a prospective study. Foot Ankle Int. 2008;29(12):1171\u20138.","journal-title":"Foot Ankle Int"},{"issue":"3","key":"5236_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0363546511431238","volume":"40","author":"O Mei-Dan","year":"2012","unstructured":"Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40(3):534\u201341.","journal-title":"Am J Sports Med"},{"issue":"8","key":"5236_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1071100715578435","volume":"36","author":"G Gormeli","year":"2015","unstructured":"Gormeli G, Karakaplan M, Gormeli CA, Sarikaya B, Elmali N, Ersoy Y. Clinical effects of platelet-rich plasma and hyaluronic acid as an additional therapy for Talar osteochondral lesions treated with microfracture surgery: a prospective randomized clinical trial. Foot Ankle Int. 2015;36(8):891\u2013900.","journal-title":"Foot Ankle Int"},{"issue":"4","key":"5236_CR42","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00167-015-3575-y","volume":"24","author":"XL Shang","year":"2016","unstructured":"Shang XL, Tao HY, Chen SY, Li YX, Hua YH. Clinical and MRI outcomes of HA injection following arthroscopic microfracture for osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1243\u20139.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"7","key":"5236_CR43","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00167-011-1856-7","volume":"20","author":"MN Doral","year":"2012","unstructured":"Doral MN, Bilge O, Batmaz G, Donmez G, Turhan E, Demirel M, et al. Treatment of osteochondral lesions of the talus with microfracture technique and postoperative hyaluronan injection. Knee Surg Sports Traumatol Arthrosc. 2012;20(7):1398\u2013403.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"5236_CR44","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"issue":"2","key":"5236_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/j.jfas.2006.12.002","volume":"46","author":"T Ibrahim","year":"2007","unstructured":"Ibrahim T, Beiri A, Azzabi M, Best AJ, Taylor GJ, Menon DK. Reliability and validity of the subjective component of the American Orthopaedic Foot and Ankle Society clinical rating scales. J Foot Ankle Surg. 2007;46(2):65\u201374.","journal-title":"J Foot Ankle Surg"},{"issue":"3","key":"5236_CR46","first-page":"233","volume":"6","author":"SH Sayyed-Hosseinian","year":"2018","unstructured":"Sayyed-Hosseinian SH, Hassankhani GG, Bagheri F, Alavi N, Shojaie B, Mousavian A. Validation of the Persian version of the American orthopedic foot and ankle society score (AOFAS) questionnaire. Arch Bone Jt Surg. 2018;6(3):233\u20139.","journal-title":"Arch Bone Jt Surg"},{"issue":"1","key":"5236_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2106\/JBJS.N.01112","volume":"97","author":"RG Marx","year":"2015","unstructured":"Marx RG, Wilson SM, Swiontkowski MF. Updating the assignment of levels of evidence. J Bone Joint Surg Am. 2015;97(1):1\u20132.","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"5236_CR48","doi-asserted-by":"publisher","first-page":"232596712091136","DOI":"10.1177\/2325967120911361","volume":"8","author":"DM Knapik","year":"2020","unstructured":"Knapik DM, Kolaczko JG, Gillespie RJ, Salata MJ, Voos JE. Complications and return to activity after arthroscopic repair of isolated type II SLAP lesions: a systematic review comparing knotted versus knotless suture anchors. Orthop J Sports Med. 2020;8(4):2325967120911361.","journal-title":"Orthop J Sports Med"},{"issue":"3","key":"5236_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"key":"5236_CR50","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic press; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"7414","key":"5236_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"Suppl 11","key":"5236_CR52","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1002\/acr.20543","volume":"63","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short Form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S240\u201352.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"5236_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semarthrit.2016.02.010","volume":"46","author":"M Johansen","year":"2016","unstructured":"Johansen M, Bahrt H, Altman RD, Bartels EM, Juhl CB, Bliddal H, et al. Exploring reasons for the observed inconsistent trial reports on intra-articular injections with hyaluronic acid in the treatment of osteoarthritis: Meta-regression analyses of randomized trials. Semin Arthritis Rheum. 2016;46(1):34\u201348.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"5236_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.arthro.2016.06.035","volume":"33","author":"H Sofu","year":"2017","unstructured":"Sofu H, Kockara N, Oner A, Camurcu Y, Issin A, Sahin V. Results of hyaluronic acid-based cell-free scaffold application in combination with microfracture for the treatment of osteochondral lesions of the knee: 2-year comparative study. Arthroscopy. 2017;33(1):209\u201316.","journal-title":"Arthroscopy"},{"issue":"3","key":"5236_CR55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00167-018-5079-z","volume":"27","author":"H Sofu","year":"2019","unstructured":"Sofu H, Camurcu Y, Ucpunar H, Ozcan S, Yurten H, Sahin V. Clinical and radiographic outcomes of chitosan-glycerol phosphate\/blood implant are similar with hyaluronic acid-based cell-free scaffold in the treatment of focal osteochondral lesions of the knee joint. Knee Surg Sports Traumatol Arthrosc. 2019;27(3):773\u201381.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"1","key":"5236_CR56","first-page":"146","volume":"68","author":"TL Huang","year":"2010","unstructured":"Huang TL, Hsu HC, Yang KC, Yao CH, Lin FH. Effect of different molecular weight hyaluronans on osteoarthritis-related protein production in fibroblast-like synoviocytes from patients with tibia plateau fracture. J Trauma. 2010;68(1):146\u201352.","journal-title":"J Trauma"},{"issue":"2","key":"5236_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/11630830-000000000-00000","volume":"26","author":"S Colen","year":"2012","unstructured":"Colen S, Haverkamp D, Mulier M, van den Bekerom MP. Hyaluronic acid for the treatment of osteoarthritis in all joints except the knee: what is the current evidence? BioDrugs. 2012;26(2):101\u201312.","journal-title":"BioDrugs"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-022-05236-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:05:58Z","timestamp":1666569958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-022-05236-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5236"],"URL":"https:\/\/doi.org\/10.1186\/s12891-022-05236-6","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JED, JSE, and RGK declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"313"}}